The J-curve between Diastolic Blood Pressure and Risk of All-cause and Cardiovascular Death. 2018

Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea.

OBJECTIVE The J-curve phenomenon between diastolic blood pressure (DBP) and mortality has been reported repeatedly in treated patients. However, the baseline risk of low DBP has not been fully explored. This study was to examine the relationship between DBP and risk of mortality from all-cause, atherosclerotic vascular diseases (ASCVD), and ischemic heart disease (IHD) using a prospective cohort of general population. METHODS We analyzed 1,234,435 participants of the Korean Cancer Prevention Study cohort (789,255 men, 30-95 years of age) who had a medical evaluation from 1992 to 1995 using Cox proportional hazards models. RESULTS A total of 22.5 million person-years were followed up (mean age 46.6 years, deaths 193,903 cases). The hazard ratios of mortality from all-cause and ASCVD, among those with DBP <60 mmHg compared to 70-79 mmHg were 1.23 (95% confidence interval [CI], 1.16-1.30) and 1.37 (95% CI, 1.20-1.57), respectively, after adjustment for multivariable including systolic blood pressure. Increased risks of all-cause death in the lowest DBP category group were maintained in men or women, 30-59 or ≥60 years of age, smoker or non-smoker and diabetes mellitus (DM) or non-DM subgroups. The risk in DBP 60-69 mmHg groups increased in several subgroups. However, the risk for ASCVD death in 30-59 years and DM group, and risk for IHD death in most subgroups except for elderly (≥60 years) decreased. CONCLUSIONS A J-curve relationship between low DBP and all-cause death was found consistently. The baseline risk in the general population may be considered for risk assessment, particularly in case of interventions that lower DBP below 60 mmHg.

UI MeSH Term Description Entries

Related Publications

Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
January 2021, Integrated blood pressure control,
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
January 1989, BMJ (Clinical research ed.),
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
June 2019, Journal of nephrology,
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
April 2013, American journal of hypertension,
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
December 2021, American heart journal plus : cardiology research and practice,
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
March 2021, Circulation,
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
October 2021, JAMA network open,
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
August 2004, The American journal of cardiology,
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
November 1988, BMJ (Clinical research ed.),
Heejin Kimm, and Yejin Mok, and Sun Ju Lee, and Sunmi Lee, and Joung Hwan Back, and Sun Ha Jee
January 1992, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!